Omnicell OMCL
NASDAQ OMCL
$34.37 -0.45 (-1.29%)
At close: Sep 4, 2026 · 4:00 PM EDT

Omnicell (OMCL) Operating Income (2010 - 2026)

Omnicell's (OMCL) quarterly Operating Income came in at $32.4 million in Q2 2026, up 299.62% year-over-year from $8.1 million in Q2 2025, and up 92.53% quarter-over-quarter from $16.9 million in Q1 2026.

Analysis

Omnicell (OMCL) Operating Income (2010 - 2026) Analysis & Trends

Omnicell (OMCL) has reported Operating Income for 17 consecutive years, with $32.4 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Operating Income rose 299.62% year-over-year to $32.4 million in Q2 2026; TTM through Jun 2026 was $58.0 million, a 274.89% increase from a year earlier, with the FY2025 full-year figure at $5.2 million, up 1431.16% from the prior year.
  • Operating Income was $32.4 million for Q2 2026 at Omnicell, up from $16.9 million in the prior quarter.
  • Over five years, Operating Income peaked at $32.4 million in Q2 2026 and troughed at -$38.4 million in Q4 2022.
  • A 5-year average of $978277.8 and a median of $5.8 million in 2022 frame the typical range for Operating Income.
  • Across the five-year window, Operating Income plunged 551.67% in 2023 and soared 299.62% in 2026, its largest moves.
  • Over 5 years, Operating Income stood at -$38.4 million in 2022, then jumped by 39.09% to -$23.4 million in 2023, then surged by 153.05% to $12.4 million in 2024, then sank by 96.65% to $415000.0 in 2025, then soared by 7719.04% to $32.4 million in 2026.
  • The last three Operating Income figures came in at $32.4 million (Q2 2026), $16.9 million (Q1 2026), and $415000.0 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Abbott Laboratories 187.42 Bn 182.47 Bn 7.27 Bn 1.69 Bn
2 Intuitive Surgical 129.78 Bn 124.69 Bn 1.96 Bn 971.90 Mn
3 Medtronic 120.53 Bn 112.33 Bn 6.34 Bn 1.76 Bn
4 Stryker 116.28 Bn 112.80 Bn 4.50 Bn 1.66 Bn
5 Boston Scientific 69.29 Bn 68.99 Bn 3.85 Bn 1.18 Bn
6 Edwards Lifesciences 51.83 Bn 47.68 Bn 1.35 Bn 513.20 Mn
7 Alcon 34.36 Bn 32.91 Bn 1.68 Bn 11.00 Mn
8 Dexcom 33.17 Bn 31.23 Bn 830.00 Mn 318.30 Mn
9 Resmed 32.94 Bn 31.47 Bn 861.22 Mn 448.71 Mn
10 Omnicell 1.57 Bn 1.28 Bn 152.94 Mn 32.45 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 32.45 Mn
Mar 31, 2026 16.85 Mn
Dec 31, 2025 415,000.00
Sep 30, 2025 8.24 Mn
Jun 30, 2025 8.12 Mn
Mar 31, 2025 -11.62 Mn
Dec 31, 2024 12.40 Mn
Sep 30, 2024 6.56 Mn
Jun 30, 2024 3.22 Mn
Mar 31, 2024 -21.85 Mn
Dec 31, 2023 -23.37 Mn
Sep 30, 2023 3.71 Mn
Jun 30, 2023 7.75 Mn
Mar 31, 2023 -22.96 Mn
Dec 31, 2022 -38.36 Mn
Sep 30, 2022 18.47 Mn
Jun 30, 2022 12.49 Mn
Mar 31, 2022 5.08 Mn
Dec 31, 2021 11.59 Mn
Sep 30, 2021 29.39 Mn